Metronomic Therapy in Metastatic Breast Cancer.
NCT01131195
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
139
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
bevacizumab, Paclitaxel
BIOLOGICAL:
Bevacizumab, Cyclophosphamide, Capecitabine
Sponsor
Swiss Cancer Institute